Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors (Q65395431)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors |
clinical trial |
Statements
A Multicenter Phase II Study of Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors (English)
0 references
9 March 2016
0 references
13 November 2018
0 references
58
0 references
18 year
0 references